<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Lauber, Emanuel</dc:creator>
  <dc:creator>Filice, Federica</dc:creator>
  <dc:creator>Schwaller, Beat</dc:creator>
  <dc:date>2018</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Due to the complex and heterogeneous etiology of autism spectrum disorder (ASD),  identification of convergent pathways and/or common molecular endpoints in the  pathophysiological processes of ASD development are highly needed in order to  facilitate treatment approaches targeted at the core symptoms. We recently reported  on decreased expression of the Ca2+-binding protein parvalbumin (PV) in three well- characterized ASD mouse models, Shank1−/−, Shank3B−/− and in utero VPA- exposed mice. Moreover, PV-deficient mice (PV+/− and PV−/−) were found to show  behavioral impairments and neuroanatomical changes closely resembling those  frequently found in human ASD individuals. Here, we combined a stereology-based  approach with molecular biology methods to assess changes in the subpopulation of  PV-expressing (Pvalb) interneurons in the recently characterized contactin-associated  protein-like 2 (Cntnap2−/−) knockout mouse model of ASD. The CNTNAP2 gene  codes for a synaptic cell adhesion molecule involved in neurodevelopmental  processes; mutations affecting the human CNTNAP2 locus are associated with  human ASD core symptoms, in particular speech and language problems. We  demonstrate that in Cntnap2−/− mice, no loss of Pvalb neurons is evident in ASD- associated brain regions including the striatum, somatosensory cortex (SSC) and  medial prefrontal cortex (mPFC), shown by the unaltered number of Pvalb neurons  ensheathed by VVA-positive perineuronal nets. However, the number of PV- immunoreactive (PV+) neurons and also PV protein levels were decreased in the  striatum of Cntnap2−/− mice indicating that PV expression levels in some striatal  Pvalb neurons dropped below the detection limit, yet without a loss of Pvalb neurons.  No changes in PV+ neuron numbers were detected in the cortical regions investigated  and also cortical PV expression levels were unaltered. Considering that Cntnap2  shows high expression levels in the striatum during human and mouse embryonic  development and that the cortico-striato-thalamic circuitry is important for speech and  language development, alterations in striatal PV expression and associated  (homeostatic) adaptations are likely to play an important role in Cntnap2−/− mice and,  assumingly, in human ASD patients with known Cntnap2 mutations.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307337</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307337/files/lau_dpe.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3389/fnmol.2018.00262</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Frontiers in Molecular Neuroscience. - 2018, vol. 11, p. 262</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Dysregulation of parvalbumin expression in the Cntnap2−/− mouse model of autism spectrum disorder</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
